Virginia Retirement Systems Et Al Cytom X Therapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$3.87 - $7.39 $581,661 - $1.11 Million	-150,300 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$4.32 - $6.43 $140,832 - $209,618	32,600 Added 27.7%	150,300 $765,000
Q2 2021 Aug 13, 2021	SELL	$6.33 - $9.91 $84,822 - $132,794	-13,400 Reduced 10.22%	117,700 $745,000
Q1 2021 Apr 30, 2021	BUY	$6.6 - $9.0 $681,780 - $929,700	103,300 Added 371.58%	131,100 $1.01 Million
Q4 2020 Feb 16, 2021	BUY	$6.47 - $7.9 $179,866 - $219,620	27,800 New	27,800 $182,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.